###begin article-title 0
###xml 57 61 <span type="species:ncbi:10090">Mice</span>
Polyoma Virus-Induced Osteosarcomas in Inbred Strains of Mice: Host Determinants of Metastasis
###end article-title 0
###begin p 1
Conceived and designed the experiments: TB. Performed the experiments: PV CKS YT JD JC RB. Analyzed the data: PV CKS TB. Wrote the paper: TB.
###end p 1
###begin p 2
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 65 69 <span type="species:ncbi:10090">mice</span>
###xml 202 207 <span type="species:ncbi:10090">mouse</span>
###xml 286 291 <span type="species:ncbi:9606">human</span>
###xml 486 490 <span type="species:ncbi:10090">mice</span>
###xml 960 964 <span type="species:ncbi:10090">mice</span>
###xml 1050 1054 <span type="species:ncbi:10090">mice</span>
###xml 1327 1331 <span type="species:ncbi:10090">mice</span>
###xml 1365 1369 <span type="species:ncbi:10090">mice</span>
###xml 1466 1470 <span type="species:ncbi:10090">mice</span>
The mouse polyoma virus induces a broad array of solid tumors in mice of many inbred strains. In most strains tumors grow rapidly but fail to metastasize. An exception has been found in the Czech-II/Ei mouse in which bone tumors metastasize regularly to the lung. These tumors resemble human osteosarcoma in their propensity for pulmonary metastasis. Cell lines established from these metastatic tumors have been compared with ones from non-metastatic osteosarcomas arising in C3H/BiDa mice. Osteopontin, a chemokine implicated in migration and metastasis, is known to be transcriptionally induced by the viral middle T antigen. Czech-II/Ei and C3H/BiDa tumor cells expressed middle T and secreted osteopontin at comparable levels as the major chemoattractant. The tumor cell lines migrated equally well in response to recombinant osteopontin as the sole attractant. An important difference emerged in assays for invasion in which tumor cells from Czech-II/Ei mice were able to invade across an extracellular matrix barrier while those from C3H/BiDa mice were unable to invade. Invasive behavior was linked to elevated levels of the metalloproteinase MMP-2 and of the transcription factor NFAT. Inhibition of either MMP-2 or NFAT inhibited invasion by Czech-II/Ei osteosarcoma cells. The metastatic phenotype is dominant in F1 mice. Osteosarcoma cell lines from F1 mice expressed intermediate levels of MMP-2 and NFAT and were invasive. Osteosarcomas in Czech-II/Ei mice retain functional p53. This virus-host model of metastasis differs from engineered models targeting p53 or pRb and provides a system for investigating the genetic and molecular basis of bone tumor metastasis in the absence of p53 loss.
###end p 2
###begin title 3
Author Summary
###end title 3
###begin p 4
###xml 471 479 471 479 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 511 518 511 518 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 14 19 <span type="species:ncbi:10090">mouse</span>
###xml 153 158 <span type="species:ncbi:10090">mouse</span>
###xml 393 397 <span type="species:ncbi:10090">mice</span>
###xml 700 705 <span type="species:ncbi:9606">human</span>
###xml 811 815 <span type="species:ncbi:10090">mice</span>
###xml 920 925 <span type="species:ncbi:9606">human</span>
###xml 1038 1046 <span type="species:ncbi:9606">patients</span>
The oncogenic mouse polyoma virus and its mutants have previously been used to investigate viral determinants of tumor induction using a standard inbred mouse strain as a common host. Here we use wild type virus to investigate the role of the host genetic background, focusing on two host strains that differ with respect to bone tumor metastasis. Comparing osteosarcoma cell lines from these mice, we have identified a molecular pathway that underlies invasive behavior in vitro and correlates with metastasis in vivo. The pathway involves secretion of the metalloproteinase MMP-2 under partial control of NFAT as a transcriptional regulator. This virus-host system reflects an important feature of human osteosarcoma with respect to pulmonary metastasis. Based on naturally occurring differences among inbred mice, the model differs from genetically engineered models targeting p53 or pRb as known risk factors in the human disease. Here, metastatic osteosarcomas retain functional p53. As noted by others, the frequency of p53 loss in patients with localized versus metastatic disease is the same, suggesting that events beyond p53 loss are important in metastasis. While the downstream effectors of metastasis in the genetically engineered models remain unknown, evidence presented here implicates upregulation of an NFAT --> MMP-2 pathway in the development of metastatic osteosarcoma.
###end p 4
###begin title 5
Introduction
###end title 5
###begin p 6
###xml 84 87 84 87 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Molloy1">[1]</xref>
###xml 437 440 437 440 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Cardiff1">[2]</xref>
###xml 503 506 503 506 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Bilger1">[3]</xref>
###xml 879 882 879 882 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Dietrich1">[4]</xref>
###xml 883 886 883 886 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Balmain1">[5]</xref>
###xml 89 94 <span type="species:ncbi:10090">Mouse</span>
###xml 140 145 <span type="species:ncbi:9606">human</span>
###xml 208 213 <span type="species:ncbi:9606">human</span>
###xml 356 371 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 588 592 <span type="species:ncbi:10090">Mice</span>
###xml 808 812 <span type="species:ncbi:10090">mice</span>
Invasion and metastasis are major factors underlying cancer morbidity and mortality [1]. Mouse models have been developed for many types of human cancer though not all present the same biological behavior as human tumors with respect to invasion and metastasis. Some models are of spontaneous origin while most are based on genetically engineered animals. Transgenic mice, mice with germline or conditional knockouts, targeted mutations [2], or ones emerging from screens following germline mutagenesis [3] have all been used to establish experimental models of specific types of cancer. Mice genetically engineered to develop cancer are typically derived from relatively few inbred strains thus reflecting a limited range of effects imposed by the host genetic background. Crosses of genetically engineered mice to other strains have been useful for identifying tumor modifiers [4],[5].
###end p 6
###begin p 7
###xml 145 148 145 148 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Benjamin1">[6]</xref>
###xml 261 264 261 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Tsai1">[7]</xref>
###xml 419 422 419 422 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Carroll1">[8]</xref>
###xml 423 426 423 426 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Bauer1">[9]</xref>
###xml 991 995 991 995 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Bronson1">[10]</xref>
###xml 996 1000 996 1000 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Freund3">[13]</xref>
###xml 4 9 <span type="species:ncbi:10090">mouse</span>
###xml 959 964 <span type="species:ncbi:10090">mouse</span>
The mouse polyoma virus (Py) is a small DNA virus that rapidly induces a variety of solid tumors in its natural host under laboratory conditions [6]. The virus establishes a disseminated infection using specific gangliosides as broadly expressed cell receptors [7]. Features of the major viral capsid protein VP1 are important in receptor discrimination and polymorphisms in VP1 are major determinants of pathogenicity [8],[9]. The replication and transforming functions of the virus reside in the T (tumor) antigens. These have been extensively characterized using cell culture systems. Expression of the T antigens leads to alterations in the regulation of growth and apoptotic pathways of the cell. These alterations involve both protooncogene activation and tumor suppressor gene inactivation. Well characterized wild type and mutant virus strains have been used to assess the roles of specific viral determinants in tumorigenesis using a standard inbred mouse strain as the common host [10]-[13].
###end p 7
###begin p 8
###xml 297 300 297 300 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Benjamin1">[6]</xref>
###xml 554 558 554 558 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Dawe1">[14]</xref>
###xml 698 702 698 702 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Schaffhausen1">[15]</xref>
###xml 858 862 858 862 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Guy1">[16]</xref>
###xml 988 992 988 992 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Jessen1">[17]</xref>
###xml 76 80 <span type="species:ncbi:10090">mice</span>
###xml 183 187 <span type="species:ncbi:10090">mice</span>
###xml 704 719 <span type="species:ncbi:10090">Transgenic mice</span>
###xml 761 786 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
###xml 883 888 <span type="species:ncbi:10090">mouse</span>
The virus can be introduced into any of a large number of inbred strains of mice to investigate effects of the host genetic background on various aspects of tumor development. Inbred mice vary greatly with respect to overall tumor frequency, spectrum of tumor types, and individual tumor behavior [6]. Py-induced tumors typically remain at the site of origin enclosed within a basement membrane. Susceptible hosts develop multiple tumors and may carry a cumulative tumor load in excess of 25% of total body weight while showing no evidence of metastasis [14]. The middle T antigen, the major viral transforming protein, activates multiple signal transduction pathways essential for tumor induction [15]. Transgenic mice expressing middle T under control of the mouse mammary tumor virus regulatory region develop mammary tumors which metastasize to the lung [16]. In this transgenic mouse system, secretion of osteopontin (OPN) was found to be necessary but not sufficient for metastasis [17].
###end p 8
###begin p 9
###xml 67 70 67 70 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Benjamin1">[6]</xref>
###xml 196 200 196 200 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Velupillai1">[18]</xref>
###xml 561 565 561 565 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-UribeBotero1">[19]</xref>
###xml 617 621 617 621 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Lukacher1">[20]</xref>
###xml 864 872 864 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 888 895 888 895 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo</italic>
###xml 34 39 <span type="species:ncbi:10090">mouse</span>
###xml 88 93 <span type="species:ncbi:10090">mouse</span>
###xml 95 97 <span type="species:ncbi:10090">CZ</span>
###xml 202 204 <span type="species:ncbi:10090">CZ</span>
###xml 205 209 <span type="species:ncbi:10090">mice</span>
###xml 445 447 <span type="species:ncbi:10090">CZ</span>
###xml 448 453 <span type="species:ncbi:10090">mouse</span>
###xml 510 515 <span type="species:ncbi:9606">human</span>
###xml 576 580 <span type="species:ncbi:10090">mice</span>
###xml 582 584 <span type="species:ncbi:10090">C3</span>
###xml 700 702 <span type="species:ncbi:10090">CZ</span>
###xml 703 708 <span type="species:ncbi:10090">mouse</span>
###xml 757 759 <span type="species:ncbi:10090">C3</span>
###xml 760 765 <span type="species:ncbi:10090">mouse</span>
In a survey of over thirty inbred mouse strains inoculated with Py [6], the Czech II/Ei mouse (CZ) emerged with unique and interesting properties. In addition to a typical array of polyoma tumors [18], CZ mice occasionally developed small nodules on the lung, normally not a site of tumor induction by the virus. These nodules proved to be metastatic lesions derived from osteosarcomas. The metastatic behavior of bone tumors in the Py-infected CZ mouse matches important clinical and pathological features of human osteosarcoma with respect to lung metastases [19]. C3H/BiDa mice (C3), a standard susceptible strain [20], develop osteosarcomas that fail to metastasize. Here we begin to explore the CZ mouse as a model of metastatic osteosarcoma using the C3 mouse as a control. A molecular pathway has been identified that correlates with properties of invasion in vitro and metastasis in vivo.
###end p 9
###begin title 10
Results/Discussion
###end title 10
###begin title 11
Bone tumor metastasis to the lung is determined by the host genetic background
###end title 11
###begin p 12
###xml 380 388 380 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g001">Figure 1</xref>
###xml 56 60 <span type="species:ncbi:10090">mice</span>
###xml 126 128 <span type="species:ncbi:10090">CZ</span>
###xml 129 133 <span type="species:ncbi:10090">mice</span>
###xml 359 361 <span type="species:ncbi:10090">CZ</span>
###xml 362 367 <span type="species:ncbi:10090">mouse</span>
###xml 770 772 <span type="species:ncbi:10090">CZ</span>
###xml 773 777 <span type="species:ncbi:10090">mice</span>
###xml 994 996 <span type="species:ncbi:10090">CZ</span>
###xml 997 1001 <span type="species:ncbi:10090">mice</span>
###xml 1117 1119 <span type="species:ncbi:10090">CZ</span>
###xml 1120 1125 <span type="species:ncbi:10090">mouse</span>
###xml 1267 1269 <span type="species:ncbi:10090">CZ</span>
###xml 1270 1274 <span type="species:ncbi:10090">mice</span>
###xml 1453 1455 <span type="species:ncbi:10090">CZ</span>
###xml 1456 1460 <span type="species:ncbi:10090">mice</span>
Osteosarcomas have previously been noted in Py-infected mice of several inbred strains but with no evidence of metastasis. In CZ mice, however, these tumors have been found to metastasize regularly to the lung. Osteosarcomas develop most frequently on the femur, skull, ribs or other long bones, and occasionally on the spine and sternum. A typical case in a CZ mouse is shown in Figure 1. The primary tumor arose on the head of the femur (panel A). This tumor showed evidence of invasion of adjacent muscle and destruction of bone (panel B). A metastatic lesion was evident as a smooth shiny nodule on the surface of the lung (panel C). This nodule showed abundant tumor cells mixed with deposits of osteoid (panel D). Lung metastases were seen in a high percentage of CZ mice by routine step-sectioning and histological examination. These lesions consistently showed production of osteoid (panel E). Metastases were noted rarely in the liver. To confirm that the liver lesions in Py-infected CZ mice also derived from osteosarcomas, cells from a primary bone tumor were inoculated subcutaneously into an uninfected CZ mouse. This animal showed growth of tumor cells in the liver with deposits of osteoid (panel F). The presence of osteoid in metastastic lesions in CZ mice confirms their origins from osteosarcomas and not from other tumor types arising in the same animals. Further support derives from the fact that no lung metastases were noted in CZ mice that failed to develop primary osteosarcoma while developing other kinds of tumors.
###end p 12
###begin title 13
###xml 40 42 <span type="species:ncbi:10090">CZ</span>
###xml 43 47 <span type="species:ncbi:10090">mice</span>
Primary and metastatic bone tumors from CZ mice.
###end title 13
###begin p 14
###xml 58 60 <span type="species:ncbi:10090">CZ</span>
###xml 61 66 <span type="species:ncbi:10090">mouse</span>
###xml 419 421 <span type="species:ncbi:10090">CZ</span>
###xml 496 498 <span type="species:ncbi:10090">CZ</span>
A) A primary bone tumor (P) on the head of the femur of a CZ mouse. B) H&E stained section of the same tumor showing invasion of adjacent muscle and destruction of bone by invading tumor cells. C) Metastatic nodule (Mx) on the surface of the lung of the same animal. D) H&E stained section of the lung metastasis from the same animal showing osteiod. E) Occult metastatic lesion with osteoid in the lung of a different CZ animal. F) H&E stained section of a liver metastasis showing osteoid in a CZ animal inoculated with osteosarcoma cells.
###end p 14
###begin p 15
###xml 339 346 339 346 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000733-t001">Table 1</xref>
###xml 17 19 <span type="species:ncbi:10090">C3</span>
###xml 20 24 <span type="species:ncbi:10090">mice</span>
###xml 44 46 <span type="species:ncbi:10090">CZ</span>
###xml 47 51 <span type="species:ncbi:10090">mice</span>
###xml 178 180 <span type="species:ncbi:10090">CZ</span>
###xml 181 185 <span type="species:ncbi:10090">mice</span>
###xml 268 270 <span type="species:ncbi:10090">CZ</span>
###xml 275 277 <span type="species:ncbi:10090">C3</span>
###xml 278 282 <span type="species:ncbi:10090">mice</span>
###xml 370 372 <span type="species:ncbi:10090">CZ</span>
###xml 373 377 <span type="species:ncbi:10090">mice</span>
###xml 507 509 <span type="species:ncbi:10090">CZ</span>
###xml 510 514 <span type="species:ncbi:10090">mice</span>
###xml 638 640 <span type="species:ncbi:10090">C3</span>
###xml 641 645 <span type="species:ncbi:10090">mice</span>
###xml 839 841 <span type="species:ncbi:10090">C3</span>
###xml 842 846 <span type="species:ncbi:10090">mice</span>
###xml 1077 1079 <span type="species:ncbi:10090">CZ</span>
###xml 1092 1094 <span type="species:ncbi:10090">C3</span>
###xml 1128 1130 <span type="species:ncbi:10090">CZ</span>
###xml 1148 1150 <span type="species:ncbi:10090">C3</span>
Osteosarcomas in C3 mice resembled those in CZ mice grossly and histologically. However, these tumors showed no evidence of lung metastasis using the same search criteria as for CZ mice. A direct comparison of the frequencies of primary and metastatic osteosarcoma in CZ and C3 mice highlights important differences between these strains (Table 1). A high proportion of CZ mice developed osteosarcomas and 90% of these were found to have metastasized to the lung. The actual frequency of lung metastasis in CZ mice may approach 100% given the likelihood that not all lesions will be found in the step sectioning process. Osteosarcomas in C3 mice were found at a lower frequency due in part to higher frequencies of other tumor types that develop early and require the animals to be sacrificed. Nevertheless, of 18 cases of osteosarcoma in C3 mice, none were found to have metastasized to the lung. The sharp difference in frequency of metastasis between hosts is not due to differences in the time allowed for tumor development. The average 'time to necropsy' was 190 days for CZ and 188 for C3, with ranges of 104-514 days for CZ and 70 - 655 for C3.
###end p 15
###begin title 16
###xml 30 32 <span type="species:ncbi:10090">CZ</span>
###xml 34 36 <span type="species:ncbi:10090">C3</span>
###xml 42 44 <span type="species:ncbi:10090">CZ</span>
###xml 47 49 <span type="species:ncbi:10090">C3</span>
###xml 54 58 <span type="species:ncbi:10090">mice</span>
Host control of metastasis in CZ, C3 and [CZ x C3] F1 mice.
###end title 16
###begin p 17
###xml 247 254 247 254 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="ppat-1000733-t001">Table 1</xref>
###xml 1 3 <span type="species:ncbi:10090">CZ</span>
###xml 6 8 <span type="species:ncbi:10090">C3</span>
###xml 13 17 <span type="species:ncbi:10090">mice</span>
###xml 126 130 <span type="species:ncbi:10090">mice</span>
###xml 160 162 <span type="species:ncbi:10090">CZ</span>
###xml 313 315 <span type="species:ncbi:10090">CZ</span>
###xml 316 320 <span type="species:ncbi:10090">mice</span>
###xml 432 434 <span type="species:ncbi:10090">C3</span>
###xml 435 439 <span type="species:ncbi:10090">mice</span>
[CZ x C3] F1 mice were infected and followed for the development of osteosarcoma and then screened for lung metastases. These mice were found to resemble their CZ parent with respect to the high frequency and metastatic behavior of osteosarcomas (Table 1). The dominance of the metastatic phenotype suggests that CZ mice express a heritable factor(s) which promotes bone tumor metastasis and which may be lacking or insufficient in C3 mice.
###end p 17
###begin title 18
###xml 0 2 <span type="species:ncbi:10090">CZ</span>
###xml 7 9 <span type="species:ncbi:10090">C3</span>
CZ and C3 bone tumor cells secrete and migrate equally well in response to osteopontin
###end title 18
###begin p 19
###xml 927 936 923 932 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g002">Figure 2A</xref>
###xml 129 131 <span type="species:ncbi:10090">CZ</span>
###xml 144 146 <span type="species:ncbi:10090">C3</span>
###xml 163 167 <span type="species:ncbi:10090">mice</span>
###xml 244 246 <span type="species:ncbi:10090">CZ</span>
###xml 340 344 <span type="species:ncbi:10090">mice</span>
###xml 452 456 <span type="species:ncbi:10090">mice</span>
###xml 692 694 <span type="species:ncbi:10090">C3</span>
To investigate the molecular basis of the metastatic phenotype, cell lines were established from primary osteosarcomas, two from CZ, three from C3 and two from F1 mice. Two additional lines were derived from lung metastatic lesions, one from a CZ and one from an F1 animal. It should be noted that no osteosarcomas were found in uninfected mice of either strain and expression of the Py T antigens was confirmed in each of the cell lines from infected mice (data not shown). The abilities of the tumor cells to migrate in response to a source of chemoattractant were tested in a transwell assay using a Boyden chamber with polycarbonate filter (8 microm pore size). Conditioned medium from a C3 osteosarcoma line was used as the attractant and serum-free medium as a control. Migration was stimulated 3-4 fold over a one hour period in response to the conditioned medium. No significant differences were noted among the lines (Figure 2A).
###end p 19
###begin title 20
Osteopontin is the major chemoattractant inducing bone tumor cell migration.
###end title 20
###begin p 21
###xml 25 26 25 26 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 94 96 <span type="species:ncbi:10090">C3</span>
###xml 504 506 <span type="species:ncbi:10090">CZ</span>
###xml 552 554 <span type="species:ncbi:10090">CZ</span>
A) Bone tumor cells (3x105) were used in a Boyden chamber assay using conditioned medium from C3 bone tumor cells as chemoattractant. Vertical bars represent mean number of cells migrating +/- S.D. Solid bars show migration using conditioned medium. Empty bars show migration using serum-free medium as a control. B) Tumor cell migration was assayed as in (A) using conditioned medium (CM) that was untreated (empty bars), pre-treated with anti-VEGF (hatched bars) or anti-OPN (solid bars). Left panel - CZ I cells with osteosarcoma CM; Middle panel - CZ I cells with hemangioma CM; Right panel - hemangioma cells with hemangioma CM. C) Tumor cell migration in response to recombinant OPN in serum-free medium (hatched bars) or serum-free medium alone (empty bars).
###end p 21
###begin p 22
###xml 471 475 471 475 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Whalen1">[21]</xref>
###xml 496 504 496 504 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 648 652 648 652 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Whalen1">[21]</xref>
###xml 799 820 799 820 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g002">Figure 2B, left panel</xref>
###xml 757 759 <span type="species:ncbi:10090">CZ</span>
###xml 1069 1071 <span type="species:ncbi:10090">CZ</span>
###xml 1076 1078 <span type="species:ncbi:10090">C3</span>
###xml 1194 1196 <span type="species:ncbi:10090">CZ</span>
###xml 1237 1239 <span type="species:ncbi:10090">C3</span>
###xml 1329 1331 <span type="species:ncbi:10090">CZ</span>
###xml 1355 1357 <span type="species:ncbi:10090">C3</span>
To identify the chemoattractant(s), the conditioned medium was first treated with antibodies to OPN or to vascular endothelial growth factor (VEGF). These factors, well recognized for their chemoattractant as well as mitogenic activities, play roles in normal bone development as well as tumor cell invasion and metastasis. OPN is of particular interest because expression of middle T has been shown to lead to transcriptional activation of OPN via two distinct pathways [21]. Furthermore, in an in vitro 'wound healing' assay, blocking induction of OPN with anti-sense RNA inhibited cell migration without interfering with transformed cell growth [21]. Pretreatment of conditioned medium with anti-OPN resulted in significant reduction in the migration of CZ-I cells while anti-VEGF had no effect (Figure 2B, left panel). Results were the same using the other lines as responding cells (data not shown). To determine whether the pathways from middle T to OPN operated equally in the two host backgrounds, levels of OPN were compared in conditioned media prepared from CZ and C3 bone tumor lines. Levels were found to be high and comparable between the two groups: 1975+/-262 pg/ml for the two CZ lines and 1592+/-38 pg/ml for the three C3 lines. Similarly, levels of VEGF, though much lower, were comparable: 153+/-12 pg/ml for CZ and 225+/-13 pg/ml for C3.
###end p 22
###begin p 23
###xml 425 434 421 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g002">Figure 2B</xref>
###xml 588 610 584 606 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g002">Figure 2B, right panel</xref>
###xml 196 198 <span type="species:ncbi:10090">C3</span>
###xml 199 204 <span type="species:ncbi:10090">mouse</span>
###xml 357 359 <span type="species:ncbi:10090">CZ</span>
Additional experiments were carried out to test the specificity of migration in relation to these factors and also with respect to tumor type. Conditioned medium from a Py-induced hemangioma in a C3 mouse contained a higher level of VEGF (792+/-38 pg/ml) and a similar level of OPN (1622+/-20 pg/ml) compared to osteosarcoma conditioned media. Migration of CZ cells was again inhibited only by anti-OPN and not by anti-VEGF (Figure 2B, middle panel). In contrast, migration of the hemangioma cells in response to its own conditioned medium was inhibited by anti-VEGF as well as anti-OPN (Figure 2B, right panel). These results confirm OPN as the major attractant for osteosarcoma cells. They also demonstrate specificity in migratory behavior based on tumor type as well as attractant.
###end p 23
###begin p 24
###xml 229 238 229 238 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g002">Figure 2C</xref>
###xml 616 620 616 620 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Jessen1">[17]</xref>
###xml 304 306 <span type="species:ncbi:10090">CZ</span>
###xml 311 313 <span type="species:ncbi:10090">C3</span>
###xml 522 537 <span type="species:ncbi:10090">transgenic mice</span>
The osteosarcoma lines were compared for their abilities to migrate in response to recombinant OPN added to serum-free medium as the sole attractant. All nine lines responded well with no significant differences among the lines (Figure 2C). We conclude that the difference in metastatic behavior between CZ and C3 osteosarcomas is not due to a difference either in production of OPN or in ability to migrate in response to this factor. This conclusion is consistent with studies of mammary tumor metastasis in Py middle T transgenic mice which indicated that factor(s) in addition to OPN are required for metastasis [17].
###end p 24
###begin title 25
###xml 0 2 <span type="species:ncbi:10090">CZ</span>
###xml 11 13 <span type="species:ncbi:10090">C3</span>
CZ but not C3 bone tumor cells show properties of invasion
###end title 25
###begin p 26
###xml 150 154 150 154 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Albini1">[22]</xref>
###xml 288 297 288 297 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g003">Figure 3A</xref>
###xml 650 658 650 658 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vivo.</italic>
###xml 837 852 837 852 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g002">Figure 2A and C</xref>
###xml 868 877 868 877 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g003">Figure 3A</xref>
###xml 32 34 <span type="species:ncbi:10090">CZ</span>
###xml 39 41 <span type="species:ncbi:10090">C3</span>
###xml 156 158 <span type="species:ncbi:10090">CZ</span>
###xml 249 251 <span type="species:ncbi:10090">C3</span>
###xml 411 415 <span type="species:ncbi:10090">mice</span>
###xml 440 442 <span type="species:ncbi:10090">CZ</span>
###xml 457 459 <span type="species:ncbi:10090">C3</span>
###xml 728 730 <span type="species:ncbi:10090">CZ</span>
###xml 738 742 <span type="species:ncbi:10090">mice</span>
An important difference between CZ and C3 osteosarcoma cell lines was seen using a 'Matrigel' invasion assay in Boyden chambers with coated membranes [22]. CZ osteosarcoma cells readily invaded across the extracellular matrix barrier in response to C3 bone tumor cell conditioned medium (Figure 3A). Migration of these cells through the barrier was stimulated 6-8 fold over a 4 hour period. Tumor cells from F1 mice behaved like those from CZ. In contrast, C3 tumor lines showed almost no ability to penetrate the coated membranes under the same conditions. The abilities of osteosarcoma cells to invade in this assay match their metastatic behavior in vivo. Tumor lines established directly from metastatic lesions in lungs of CZ and F1 mice behaved similarly to those from primary tumors with respect to their properties of migration (Figure 2A and C) and invasion (Figure 3A).
###end p 26
###begin title 27
Metastatic tumor cells invade Matrigel via an MMP-2-mediated pathway.
###end title 27
###begin p 28
###xml 41 50 41 50 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g002">Figure 2A</xref>
A) Migration assay was carried out as in Figure 2A except the upper surface of the filter was coated with Matrigel. B) Upper - Zymography with gelatin as 'in gel' substrate and conditioned media from each of the tumor lines. Lower - Immunoblot for MMP-2 in tumor cell lysates.
###end p 28
###begin title 29
Invasion is linked to elevated levels of the metalloproteinase MMP-2 and of NFAT as an upstream regulator
###end title 29
###begin p 30
###xml 480 484 480 484 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Loukopoulos1">[23]</xref>
###xml 601 610 589 598 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g003">Figure 3B</xref>
###xml 17 19 <span type="species:ncbi:10090">CZ</span>
###xml 655 657 <span type="species:ncbi:10090">CZ</span>
###xml 731 733 <span type="species:ncbi:10090">C3</span>
The abilities of CZ and F1 tumor cells to penetrate 'Matrigel' suggests the involvement of one or more matrix metalloproteinases (MMPs). A zymograph assay was used to identify MMPs and estimate their levels of secretion. Conditioned medium from each of the tumor cell lines was concentrated as sources of enzyme(s). Gelatin was used as a substrate in the 'in gel' assay for detection of MMP-2 or MMP-9, two metalloproteinases linked to invasion and metastasis by bone tumor cells [23]. Clearing of the gel was seen at a single position of approximately70kD corresponding in molecular weight to MMP-2 (Figure 3B, top). Clearing was strongest for the three CZ tumors and somewhat weaker for the F1 tumors. Conditioned media from the C3 cell lines produced little or no clearing of the gel.
###end p 30
###begin p 31
###xml 308 317 308 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g003">Figure 3B</xref>
###xml 770 779 764 773 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g003">Figure 3B</xref>
###xml 270 272 <span type="species:ncbi:10090">CZ</span>
###xml 292 294 <span type="species:ncbi:10090">C3</span>
###xml 547 549 <span type="species:ncbi:10090">C3</span>
###xml 610 612 <span type="species:ncbi:10090">CZ</span>
###xml 641 643 <span type="species:ncbi:10090">CZ</span>
###xml 717 719 <span type="species:ncbi:10090">C3</span>
###xml 855 857 <span type="species:ncbi:10090">CZ</span>
###xml 860 862 <span type="species:ncbi:10090">C3</span>
Tumor cell extracts were tested to confirm the presence of MMP-2 and to compare levels among the lines. Extracts were separated by SDS gel electrophoresis and immunoblotted with anti-MMP-2 antibody. MMP-2 was detected in each of the cell lines but levels were higher in CZ and F1 compared to C3 tumor cells (Figure 3B, bottom). Levels of endogenous MMP-2 were estimated by densitometry. Values were normalized to loading controls and averaged for the cell lines based on host of origin. The values (arbitrary units) were 1.14+/-0.22 for the three C3 lines, 3.79+/-0.27 for the F1 lines and 5.18+/-1.37 for the CZ lines. The tumor cells from CZ thus expresses 4 to 5 fold higher levels of the protease than those from C3. Comparison of the zymograph with the immunoblot (Figure 3B) suggests that secreted levels of MMP-2 may be even more disproportionate (CZ > C3). This would indicate that differences in the secretory pathway or extracellular activation of the enzyme may also contribute to the ability to invade. Other MMPs not directly tested for here may also be involved.
###end p 31
###begin p 32
###xml 158 162 158 162 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Rao1">[24]</xref>
###xml 255 259 255 259 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-AlfonsoJaume1">[25]</xref>
###xml 260 264 260 264 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Jauliac1">[26]</xref>
###xml 487 491 487 491 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Pan1">[27]</xref>
###xml 492 496 492 496 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Sherman1">[28]</xref>
###xml 582 591 582 591 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g004">Figure 4A</xref>
###xml 887 891 881 885 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Luo1">[29]</xref>
###xml 985 989 979 983 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Chen1">[30]</xref>
###xml 1072 1081 1066 1075 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g004">Figure 4B</xref>
###xml 50 52 <span type="species:ncbi:10090">CZ</span>
###xml 72 74 <span type="species:ncbi:10090">C3</span>
###xml 556 558 <span type="species:ncbi:10090">CZ</span>
###xml 578 580 <span type="species:ncbi:10090">C3</span>
###xml 705 707 <span type="species:ncbi:10090">C3</span>
###xml 756 758 <span type="species:ncbi:10090">CZ</span>
###xml 991 993 <span type="species:ncbi:10090">CZ</span>
###xml 1062 1064 <span type="species:ncbi:10090">C3</span>
The finding of higher levels of MMP-2 secreted by CZ and F1 compared to C3 tumor cells raises the possibility of involvement of the transcription factor NFAT [24]. NFAT is known to regulate the expression of MMPs and to be involved in tumor cell invasion [25],[26]. To test this possibility, tumor cell extracts were separated and blotted with antibody to NFATc1. This antibody detects three alternatively spliced species among which there are no well established functional differences [27],[28]. The levels of all three were elevated in tumor cells from CZ and F1 compared to C3 (Figure 4A). Relative levels of NFAT based on scanning across all isoforms were as follows (arbitrary units): for the three C3 lines 384.3+/-68.4, for F1 676.7+/-58.5 and for CZ 1038.7+/-157.3. To measure levels of activated NFAT, tumor cells were transfected with a luciferase reporter responsive to NFAT [29]. This reporter carries elements from the IL-2 promoter and is known to be responsive to NFAT [30]. CZ and F1 cells showed 3-4 fold activation of the reporter compared to C3 cells (Figure 4B). These results demonstrate higher levels of expression and activation NFATc1 in the metastatic compared to the non-metastatic osteosarcoma cell lines.
###end p 32
###begin title 33
Activation of NFAT and secretion of MMP-2 are critical for invasion by metastatic bone tumor cells.
###end title 33
###begin p 34
###xml 148 150 <span type="species:ncbi:10090">CZ</span>
A) Immunoblot for NFAT c1 in tumor cell lysates. B) Normalized luciferase activity of an NFAT reporter in tumor cells. C) Inhibition of invasion by CZ II tumor cells. Left: cells +/- TIMP-2. Middle: cells +/- NFAT siRNA. Right: immunoblots on cells +/- NFAT siRNA.
###end p 34
###begin p 35
###xml 180 184 180 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Ries1">[31]</xref>
###xml 185 189 185 189 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Visse1">[32]</xref>
###xml 258 267 258 267 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g004">Figure 4C</xref>
###xml 110 112 <span type="species:ncbi:10090">CZ</span>
###xml 685 687 <span type="species:ncbi:10090">CZ</span>
###xml 963 965 <span type="species:ncbi:10090">CZ</span>
###xml 973 977 <span type="species:ncbi:10090">mice</span>
To test for the functional importance of MMP-2 and NFAT, 'Matrigel' invasion assays were carried out with the CZ II line in the presence of TIMP-2 as a specific inhibitor of MMP-2 [31],[32], or following transfection with siRNAs to suppress NFAT expression (Figure 4C). Addition of TIMP-2 resulted in a 3 to 4 fold inhibition of invasion. Two siRNAs were used to directly inhibit expression of NFAT. Both were effective in reducing NFAT levels with concomitant effects on MMP-2. Importantly, both were effective in inhibiting invasion. siRNA2 was particularly effective, reducing MMP-2 levels 4 to 5 fold and blocking invasion 6 to 7 fold. Similar results were obtained with all three CZ and all three F1 lines. Thus, treatments targeting either the protease or its upstream regulator result in inhibition of invasion. These results suggest that operation of an NFAT --> MMP-2 pathway at elevated levels contributes to the metastatic behavior of osteosarcomas in CZ and F1 mice.
###end p 35
###begin title 36
###xml 4 6 <span type="species:ncbi:10090">CZ</span>
###xml 7 12 <span type="species:ncbi:10090">mouse</span>
The CZ mouse model of osteosarcoma differs from genetically engineered models
###end title 36
###begin p 37
###xml 432 436 432 436 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Jacks1">[33]</xref>
###xml 437 441 437 441 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Olive1">[35]</xref>
###xml 622 626 622 626 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Walkley1">[36]</xref>
###xml 627 631 627 631 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Berman1">[37]</xref>
###xml 842 846 842 846 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Gokgoz1">[38]</xref>
###xml 8 13 <span type="species:ncbi:10090">mouse</span>
###xml 291 295 <span type="species:ncbi:10090">Mice</span>
###xml 746 754 <span type="species:ncbi:9606">patients</span>
###xml 809 817 <span type="species:ncbi:9606">patients</span>
Several mouse models of osteosarcoma have been developed based on loss or alteration of p53 or pRb. These reflect the occurrence of osteosarcoma in families with germline mutations in these tumor suppressor genes and with their frequent somatic alterations in sporadic cases of the disease. Mice with germline loss of p53 or ones expressing certain gain-of-function mutants develop osteosarcoma along with a variety of other tumors [33]-[35]. Loss of pRb by itself has not been noted to give rise to osteosarcoma, but when coupled to p53-deficiency or mutant p53, pRb deficiency potentiates the development of the disease [36],[37]. Variable rates of metastasis are found in these models. Interestingly, the frequency of p53 loss in osteosarcoma patients with localized disease was found to be the same as in patients with metastatic disease [38], suggesting that events beyond loss of p53 are important in metastasis. The events that give rise to metastasis following disruption of the transcriptional regulatory functions of these tumor suppressors are not known.
###end p 37
###begin p 38
###xml 376 380 376 380 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Dey1">[39]</xref>
###xml 588 596 588 596 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="ppat-1000733-g005">Figure 5</xref>
###xml 770 779 770 779 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1/Waf1</sup>
###xml 857 861 857 861 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Dahl1">[40]</xref>
###xml 987 991 987 991 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Larose1">[41]</xref>
###xml 1080 1084 1080 1084 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Freund1">[11]</xref>
###xml 1168 1172 1168 1172 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Guy1">[16]</xref>
###xml 59 61 <span type="species:ncbi:10090">CZ</span>
###xml 62 66 <span type="species:ncbi:10090">mice</span>
###xml 150 152 <span type="species:ncbi:10090">CZ</span>
###xml 157 159 <span type="species:ncbi:10090">C3</span>
###xml 160 164 <span type="species:ncbi:10090">mice</span>
###xml 428 430 <span type="species:ncbi:10090">CZ</span>
###xml 498 500 <span type="species:ncbi:10090">CZ</span>
###xml 502 504 <span type="species:ncbi:10090">C3</span>
###xml 512 516 <span type="species:ncbi:10090">mice</span>
###xml 715 721 <span type="species:ncbi:9606">humans</span>
###xml 1152 1167 <span type="species:ncbi:10090">transgenic mice</span>
###xml 1244 1246 <span type="species:ncbi:10090">CZ</span>
###xml 1248 1250 <span type="species:ncbi:10090">C3</span>
###xml 1258 1262 <span type="species:ncbi:10090">mice</span>
###xml 1407 1409 <span type="species:ncbi:10090">CZ</span>
###xml 1414 1416 <span type="species:ncbi:10090">C3</span>
###xml 1417 1421 <span type="species:ncbi:10090">mice</span>
The predisposition to bone tumor metastasis in Py-infected CZ mice is dominantly inherited and presumed to be independent of p53 or pRb loss. Neither CZ nor C3 mice develop spontaneous tumors at a rate that would suggest the absence or altered function of p53 or pRb. Polyoma is unusual among the oncogenic DNA tumor viruses in its failure to inhibit or degrade p53 in tumors [39]. The possibility of spontaneous loss of p53 in CZ osteosarcomas was nevertheless investigated. Tumor cell lines from CZ, C3 and F1 mice were examined for p53 expression and for their response to DNA damage (Figure 5). Cells were exposed to actinomycin D (10-50 nM) for 24 hours. This led to phosphorylation on serine-18 (serine-15 in humans) and accumulation of p53 and to induction of p21Cip1/Waf1, as previously shown for cells in culture productively infected by the virus [40]. Similar results were found for the other lines (data not shown). pRb function is disrupted by binding to Py large T antigen [41]. However, the ability of the virus to induce tumors does not depend on this interaction [11], and metastatic mammary tumors develop without large T in middle T transgenic mice [16]. The large T-pRb interaction is expected to occur equally in tumors of CZ, C3 and F1 mice. While disruption of pRb by large T may be necessary for metastatic behavior, it is not sufficient. It thus appears that the difference between CZ and C3 mice with respect to bone tumor metastasis is based on host genetic factor(s) unrelated to p53 loss or to the action of the virus on pRb.
###end p 38
###begin title 39
###xml 24 33 24 33 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Cip1/Waf1</sup>
Induction of p53 and p21Cip1/Waf1 in a DNA damage response in metastatic and non-metastatic bone tumor cell lines.
###end title 39
###begin p 40
Cell extracts were separated by SDS-PAGE and immunoblotted as indicated. ActD - actinomycin D.
###end p 40
###begin p 41
###xml 229 237 229 237 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 533 537 533 537 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Luo1">[29]</xref>
###xml 640 644 640 644 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Giannelli1">[42]</xref>
###xml 10 15 <span type="species:ncbi:9606">human</span>
###xml 82 87 <span type="species:ncbi:10090">mouse</span>
###xml 207 209 <span type="species:ncbi:10090">CZ</span>
###xml 384 386 <span type="species:ncbi:10090">CZ</span>
###xml 387 391 <span type="species:ncbi:10090">mice</span>
As in the human disease, the downstream effectors of metastasis in the engineered mouse models remain largely unknown. Elevated expression of MMP-2 and NFAT are important factors in the invasive behavior of CZ osteosarcoma cells in vitro. Enhanced operation of a pathway linking these factors provides a plausible mechanism contributing to the metastatic behavior of osteosarcomas in CZ mice. The genetic determinant(s) of metastasis in this system nevertheless remain unknown. Factors that impinge on calcineurin activation of NFAT [29], on secretion or activation of MMPs, expression of specific integrins involved in tumor cell invasion [42], and microenvironmental influences in the lung are among many additional factors that may be involved. Mapping and identifying genetic determinants in this system will be necessary to confirm the importance of the NFAT-->MMP-2 pathway and to fully establish the molecular basis of metastasis.
###end p 41
###begin title 42
Materials and Methods
###end title 42
###begin title 43
###xml 23 27 <span type="species:ncbi:10090">mice</span>
Induction of tumors in mice
###end title 43
###begin p 44
###xml 308 309 292 293 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">6</sup>
###xml 400 404 384 388 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Dawe1">[14]</xref>
###xml 11 15 <span type="species:ncbi:10090">mice</span>
###xml 66 70 <span type="species:ncbi:10090">mice</span>
###xml 208 212 <span type="species:ncbi:10090">mice</span>
###xml 422 426 <span type="species:ncbi:10090">mice</span>
Czech II/E mice (Jackson Laboratory, Bar Harbor, ME) and C3H/BiDa mice (National Cancer Institute, Frederick, MD) were maintained in our SPF barrier animal facility. No spontaneous tumors were noted. Newborn mice were inoculated i.p. with approximately50 microl of a crude virus suspension (RA strain, 2-5x106 PFU), transferred to a separate facility and monitored for tumor development as described [14]. The methods for mice use and care were approved by the Harvard Medical Area Standing Committee on Animals ("HMA IACUC"), and are in accordance with PHS policy on Care and Use of Laboratory Animals under the guidance of the Office of Laboratory Animal Welfare (OLAW) within the NIH. Histology was carried out through the Rodent Histopathology Core of the Dana Farber-Harvard Cancer Center. Screening for lung metastases was carried out by step-sectioning and microscopic examination. A total of five sections (5 micro) taken 100 micro apart were examined.
###end p 44
###begin title 45
Osteosarcoma cell lines and conditioned media
###end title 45
###begin p 46
###xml 373 375 <span type="species:ncbi:10090">CZ</span>
###xml 382 384 <span type="species:ncbi:10090">CZ</span>
###xml 429 431 <span type="species:ncbi:10090">CZ</span>
###xml 432 436 <span type="species:ncbi:10090">mice</span>
###xml 438 440 <span type="species:ncbi:10090">CZ</span>
###xml 479 484 <span type="species:ncbi:10090">mouse</span>
###xml 488 490 <span type="species:ncbi:10090">CZ</span>
###xml 494 496 <span type="species:ncbi:10090">C3</span>
###xml 500 502 <span type="species:ncbi:10090">C3</span>
###xml 510 512 <span type="species:ncbi:10090">C3</span>
###xml 576 578 <span type="species:ncbi:10090">C3</span>
###xml 579 583 <span type="species:ncbi:10090">mice</span>
###xml 616 620 <span type="species:ncbi:10090">mice</span>
###xml 663 668 <span type="species:ncbi:10090">mouse</span>
Osteosarcomas were removed at necropsy, cut into small fragments, washed and digested at 37degrees C overnight in medium containing 200 U/ml Collagenase, Type 1 (Worthington). Cells were spun out, resuspended and plated in DMEM containing 10% FBS. Cells were expanded initially to five 10 cm dishes and frozen. All experiments were carried out within 2-5 further passages. CZ-I and CZ-II are from osteosarcomas in two individual CZ mice. CZ-Mx is a lung metastasis from the same mouse as CZ-I. C3-I, C3-II and C3-III are non-metastatic osteosarcma lines from three individual C3 mice. F1-I and F1-II are from two F1 mice. F1-Mx is a lung metastasis from the same mouse as F1-I. Conditioned medium was prepared from confluent cultures of cells grown in DMEM with 10% FBS. Cultures were washed and incubated at 37degreesC overnight in serum-free DMEM. Media were concentrated ten fold using centrifugal filter devices (Millipore Corporation). Concentrates were filter sterilized and stored at -80degreesC. Levels of OPN and VEGF in conditioned media were determined by double sandwich ELISA.
###end p 46
###begin title 47
Assays for migration and invasion
###end title 47
###begin p 48
###xml 69 73 69 73 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Albini1">[22]</xref>
###xml 190 191 186 187 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
###xml 865 866 843 844 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">5</sup>
Tumor cell migration and invasion were assayed using Boyden chambers [22] with polycarbonate membranes (8 microm pore size; 6.5 mm diameter from Corning Inc., Corning, NY). Tumor cells (3x105/well in DMEM with 0.1% BSA) were placed in the upper compartment and either conditioned medium or recombinant osteopontin (4 microg/well; R&D Systems, Inc., Minneapolis, MN) in the lower compartment. Incubation was at 37degreesC for 1 h. Where indicated, conditioned medium was neutralized with anti-OPN or anti-VEGF antibody (5 microg/well; R&D Systems, Inc). After removal of cells from the upper side of the filter, cells on the bottom side were stained by crystal violet and counted over 7 randomly chosen fields. Invasion assays were performed in the same manner except that the polycarbonate filters were coated with ECM gel (20 microg/well; Sigma). Tumor cells (5x105) were added to the upper chamber and incubated for 4 h at 37degreesC.
###end p 48
###begin title 49
Gelatin zymography
###end title 49
###begin p 50
###xml 41 45 41 45 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="ppat.1000733-Wang1">[43]</xref>
Procedures were essentially as described [43]. Acetone precipitates of concentrated conditioned media were resuspended and separated on 10% polyacrylamide gel containing 1 mg/mL gelatin.
###end p 50
###begin title 51
Immunoblotting
###end title 51
###begin p 52
###xml 312 317 <span type="species:ncbi:10090">mouse</span>
###xml 331 337 <span type="species:ncbi:9986">rabbit</span>
Cell extracts were separated by SDS-PAGE, transferred and blotted with antibody against NFAT c1 (Santa Cruz Biotech, Santa Cruz, CA), MMP-2 (Santa Cruz Biotech), phospho-p53 (ser-15) (Cell Signaling, Beverly, MA), or p21 (C-19) (Santa Cruz Biotech). Membranes were washed and incubated with Alexa fluor 680 anti-mouse and 800 anti-rabbit IgG antibodies (Invitrogen, Carlsbad, CA). Odyssey infrared imaging system (LI-COR Biosciences, Lincoln, NE) was used to reveal band intensities and integrated intensity values were obtained using LI-COR Odyssey software (Li-COR Biosciences).
###end p 52
###begin title 53
Luciferase assay
###end title 53
###begin p 54
Cells were cotransfected with pTL-Renilla vector and pGL3 basic or pGL3 containing IL2 promoter by using Lipofectamin 2000 (Invitrogen) according to the manufacturer's protocol. At 24 hr, cells were harvested, washed and lysed with 100 microl of Passive lysis buffer (Promega, Madison, WI) at 4degreesC for 15 min. Twenty microliters of the cell lysate and a Dual assay kit (Promega) were used to measure fluorescence intensities. Firefly luciferase activities were normalized to those of renilla luciferase.
###end p 54
###begin title 55
siRNA transfection and TIMP-2 treatment
###end title 55
###begin p 56
###xml 324 326 <span type="species:ncbi:10090">CZ</span>
Cells were transfected with NFATc1 siRNA (NFATC1MSS275981 and NFATC1MSS275982; Invitrogen) or Stealth RNAi Negative Control Duplex (Invitrogen) using Oligofectamin and Opti-MEM medium (Invitrogen). Levels of NFAT at 24 hr post- transfection, were determined by immunoblotting. TIMP-2 (400 ng/ml, Sigma) was used to pretreat CZ and F1 bone tumor cells for 30 min and was added to the upper and lower chambers during the assay.
###end p 56
###begin title 57
Accession numbers (UniProtKB/Swiss-Prot)
###end title 57
###begin p 58
###xml 27 35 27 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">: P33434</bold>
72 kDa type IV collagenase : P33434 (MMP2_MOUSE)
###end p 58
###begin p 59
###xml 51 59 51 59 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">: O88942</bold>
Nuclear factor of activated T-cells, cytoplasmic 1 : O88942 (NFATc1_MOUSE)
###end p 59
###begin p 60
###xml 12 20 12 20 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">: P10923</bold>
Osteopontin : P10923 (Osteopontin_MOUSE)
###end p 60
###begin p 61
###xml 29 35 29 35 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P02340</bold>
Cellular tumor antigen p53 : P02340 (P53_MOUSE)
###end p 61
###begin p 62
###xml 32 38 32 38 <bold xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P25785</bold>
Metalloproteinase inhibitor 2 : P25785 (TIMP2_MOUSE)
###end p 62
###begin p 63
The authors would like to thank Dr. Anjana Rao for the IL-2-Luc reporter and Drs Andrew Wagner, Kate Janeway and Alex Toker for helpful discussions.
###end p 63
###begin title 64
References
###end title 64
###begin article-title 65
Recent advances in metastasis research.
###end article-title 65
###begin article-title 66
###xml 58 62 <span type="species:ncbi:10090">Mice</span>
Chapter 24. The Tumor Pathology of Genetically Engineered Mice: A New Approach to Molecular Pathology.
###end article-title 66
###begin article-title 67
###xml 20 25 <span type="species:ncbi:10090">mouse</span>
Manipulation of the mouse germline in the study of Min-induced neoplasia.
###end article-title 67
###begin article-title 68
###xml 106 111 <span type="species:ncbi:10090">mouse</span>
Genetic identification of Mom-1, a major modifier locus affecting Min-induced intestinal neoplasia in the mouse.
###end article-title 68
###begin article-title 69
###xml 27 31 <span type="species:ncbi:10090">mice</span>
Cancer resistance genes in mice: models for the study of tumour modifiers.
###end article-title 69
###begin article-title 70
Chapter 5. Polyoma Viruses.
###end article-title 70
###begin article-title 71
###xml 31 37 <span type="species:ncbi:10090">murine</span>
###xml 56 60 <span type="species:ncbi:10633?0.9966199903428296">SV40</span>
Gangliosides are receptors for murine polyoma virus and SV40.
###end article-title 71
###begin article-title 72
###xml 81 85 <span type="species:ncbi:10090">mice</span>
Receptor-binding and oncogenic properties of polyoma viruses isolated from feral mice.
###end article-title 72
###begin article-title 73
Genetic and structural analysis of a virulence determinant in polyomavirus VP1.
###end article-title 73
###begin article-title 74
Tumor induction by a transformation-defective polyoma virus mutant blocked in signaling through Shc.
###end article-title 74
###begin article-title 75
Separation of immortalization from tumor induction with polyoma large T mutants that fail to bind the retinoblastoma gene product.
###end article-title 75
###begin article-title 76
###xml 32 36 <span type="species:ncbi:10090">mice</span>
Polyomavirus tumor induction in mice: effects of polymorphisms of VP1 and large T antigen.
###end article-title 76
###begin article-title 77
###xml 68 72 <span type="species:ncbi:10090">mice</span>
Changes in frequency, morphology, and behavior of tumors induced in mice by a polyoma virus mutant with a specifically altered oncogene.
###end article-title 77
###begin article-title 78
###xml 71 75 <span type="species:ncbi:10090">mice</span>
Variations in polyoma virus genotype in relation to tumor induction in mice. Characterization of wild type strains with widely differing tumor profiles.
###end article-title 78
###begin article-title 79
Lessons from polyoma middle T antigen on signaling and transformation: A DNA tumor virus contribution to the war on cancer.
###end article-title 79
###begin article-title 80
###xml 90 95 <span type="species:ncbi:10090">mouse</span>
Induction of mammary tumors by expression of polyomavirus middle T oncogene: a transgenic mouse model for metastatic disease.
###end article-title 80
###begin article-title 81
###xml 60 65 <span type="species:ncbi:10090">mouse</span>
Molecular analysis of metastasis in a polyomavirus middle T mouse model: the role of osteopontin.
###end article-title 81
###begin article-title 82
###xml 20 24 <span type="species:ncbi:10090">mice</span>
Wild-derived inbred mice have a novel basis of susceptibility to polyomavirus-induced tumors.
###end article-title 82
###begin article-title 83
Primary osteosarcoma of bone. Clinicopathologic investigation of 243 cases, with necropsy studies in 54.
###end article-title 83
###begin article-title 84
###xml 80 105 <span type="species:ncbi:11757">mouse mammary tumor virus</span>
Susceptibility to tumors induced by polyoma virus is conferred by an endogenous mouse mammary tumor virus superantigen.
###end article-title 84
###begin article-title 85
Polyomavirus middle T antigen induces the transcription of osteopontin, a gene important for the migration of transformed cells.
###end article-title 85
###begin article-title 86
Tumor and endothelial cell invasion of basement membranes. The matrigel chemoinvasion assay as a tool for dissecting molecular mechanisms.
###end article-title 86
###begin article-title 87
Characterisation of three novel canine osteosarcoma cell lines producing high levels of matrix metalloproteinases.
###end article-title 87
###begin article-title 88
Transcription factors of the NFAT family: regulation and function.
###end article-title 88
###begin article-title 89
Co-operative interactions between NFAT (nuclear factor of activated T cells) c1 and the zinc finger transcription factors Sp1/Sp3 and Egr-1 regulate MT1-MMP (membrane type 1 matrix metalloproteinase) transcription by glomerular mesangial cells.
###end article-title 89
###begin article-title 90
The role of NFAT transcription factors in integrin-mediated carcinoma invasion.
###end article-title 90
###begin article-title 91
###xml 53 59 <span type="species:ncbi:10090">murine</span>
Molecular cloning and functional characterization of murine cDNA encoding transcription factor NFATc.
###end article-title 91
###begin article-title 92
###xml 62 68 <span type="species:ncbi:10090">murine</span>
NF-ATc isoforms are differentially expressed and regulated in murine T and mast cells.
###end article-title 92
###begin article-title 93
Recombinant NFAT1 (NFATp) is regulated by calcineurin in T cells and mediates transcription of several cytokine genes.
###end article-title 93
###begin article-title 94
Structure of the DNA-binding domains from NFAT, Fos and Jun bound specifically to DNA.
###end article-title 94
###begin article-title 95
###xml 70 75 <span type="species:ncbi:9606">human</span>
MMP-2, MT1-MMP, and TIMP-2 are essential for the invasive capacity of human mesenchymal stem cells: differential regulation by inflammatory cytokines.
###end article-title 95
###begin article-title 96
Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry.
###end article-title 96
###begin article-title 97
###xml 38 42 <span type="species:ncbi:10090">mice</span>
Tumor spectrum analysis in p53-mutant mice.
###end article-title 97
###begin article-title 98
###xml 49 54 <span type="species:ncbi:10090">mouse</span>
Gain of function of a p53 hot spot mutation in a mouse model of Li-Fraumeni syndrome.
###end article-title 98
###begin article-title 99
###xml 35 40 <span type="species:ncbi:10090">mouse</span>
Mutant p53 gain of function in two mouse models of Li-Fraumeni syndrome.
###end article-title 99
###begin article-title 100
###xml 12 17 <span type="species:ncbi:10090">mouse</span>
###xml 96 101 <span type="species:ncbi:9606">human</span>
Conditional mouse osteosarcoma, dependent on p53 loss and potentiated by loss of Rb, mimics the human disease.
###end article-title 100
###begin article-title 101
Metastatic osteosarcoma induced by inactivation of Rb and p53 in the osteoblast lineage.
###end article-title 101
###begin article-title 102
###xml 31 39 <span type="species:ncbi:9606">patients</span>
Comparison of p53 mutations in patients with localized osteosarcoma and metastatic osteosarcoma.
###end article-title 102
###begin article-title 103
###xml 108 113 <span type="species:ncbi:10090">mouse</span>
Accelerated development of polyoma tumors and embryonic lethality: different effects of p53 loss on related mouse backgrounds.
###end article-title 103
###begin article-title 104
Induction and utilization of an ATM signaling pathway by polyomavirus.
###end article-title 104
###begin article-title 105
Polyomavirus large T mutants affected in retinoblastoma protein binding are defective in immortalization.
###end article-title 105
###begin article-title 106
Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion.
###end article-title 106
###begin article-title 107
Stimulation of pro-MMP-2 production and activation by native form of extracellular type I collagen in cultured hepatic stellate cells.
###end article-title 107
###begin p 108
The authors have declared that no competing interests exist.
###end p 108
###begin p 109
This work has been supported by grant RO1 CA-90992 from the National Cancer Institute of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
###end p 109

